Why it matters: Novo has struggled to stay competitive with Eli Lilly LLY in developing the next generation of obesity drugs that could improve on Lillys Zepbound, with disappointing data for phase 2 drug monlunabant in September and phase 3 GLP-1 and amylin combination cagrisema in December
Unlike aggressive dosing that prioritizes rapid weight loss, microdosing shifts body composition more muscle, less visceral fat and produces fewer side effects
It also provides strategies for managing symptoms and discusses evidence-based treatment options, like hormone replacement therapy
So thats why if you ask people, many studies on dreaming have shown that people, when they dream, they dream about people, they dream about dogs and cats, they dream about, you know, the amount of time they spend talking on the telephone or watching TV is actually similar to what it is in waking life
Reward yourself with non-food treats like a spa day, a new outfit, or a relaxing experience at Pure Med Spa Chicago